FR2341305A1 - NEW TABLETS AND NEW COMPOSITION FOR THE TREATMENT OF DISORDERS OF THE CEREBRAL CIRCULATORY SYSTEM, AND THEIR PREPARATION - Google Patents

NEW TABLETS AND NEW COMPOSITION FOR THE TREATMENT OF DISORDERS OF THE CEREBRAL CIRCULATORY SYSTEM, AND THEIR PREPARATION

Info

Publication number
FR2341305A1
FR2341305A1 FR7705292A FR7705292A FR2341305A1 FR 2341305 A1 FR2341305 A1 FR 2341305A1 FR 7705292 A FR7705292 A FR 7705292A FR 7705292 A FR7705292 A FR 7705292A FR 2341305 A1 FR2341305 A1 FR 2341305A1
Authority
FR
France
Prior art keywords
new
disorders
preparation
treatment
circulatory system
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7705292A
Other languages
French (fr)
Other versions
FR2341305B1 (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of FR2341305A1 publication Critical patent/FR2341305A1/en
Application granted granted Critical
Publication of FR2341305B1 publication Critical patent/FR2341305B1/fr
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/475—Quinolines; Isoquinolines having an indole ring, e.g. yohimbine, reserpine, strychnine, vinblastine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
FR7705292A 1976-02-23 1977-02-23 NEW TABLETS AND NEW COMPOSITION FOR THE TREATMENT OF DISORDERS OF THE CEREBRAL CIRCULATORY SYSTEM, AND THEIR PREPARATION Granted FR2341305A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH217776 1976-02-23

Publications (2)

Publication Number Publication Date
FR2341305A1 true FR2341305A1 (en) 1977-09-16
FR2341305B1 FR2341305B1 (en) 1981-01-16

Family

ID=4227685

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7705292A Granted FR2341305A1 (en) 1976-02-23 1977-02-23 NEW TABLETS AND NEW COMPOSITION FOR THE TREATMENT OF DISORDERS OF THE CEREBRAL CIRCULATORY SYSTEM, AND THEIR PREPARATION

Country Status (9)

Country Link
AU (1) AU516531B2 (en)
BE (1) BE851702A (en)
DE (1) DE2707763A1 (en)
FR (1) FR2341305A1 (en)
GB (1) GB1569036A (en)
GR (1) GR70334B (en)
NL (1) NL7701869A (en)
PT (1) PT66201B (en)
ZA (1) ZA771079B (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0142877A2 (en) * 1983-10-24 1985-05-29 "PHARLYSE", Société Anonyme Pharmaceutical tablets with prolonged action, their preparation and their use

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5762277A (en) * 1980-06-23 1982-04-15 Ciba Geigy Ag Manufacture of effect-enduring vincamine blend, obtained vincamine blend and medicine
NZ211545A (en) * 1984-04-11 1987-09-30 Ici Australia Ltd Composition having particulate trace element suspended in matrix of solid polyethylene glycol
IE58110B1 (en) * 1984-10-30 1993-07-14 Elan Corp Plc Controlled release powder and process for its preparation
RU2525433C2 (en) * 2011-10-05 2014-08-10 Общество С Ограниченной Ответственностью "Фарма Старт" Medication vincamin in form of matrix tablets for improvement of cerebral circulation and method of its manufacturing

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0142877A2 (en) * 1983-10-24 1985-05-29 "PHARLYSE", Société Anonyme Pharmaceutical tablets with prolonged action, their preparation and their use
EP0142877A3 (en) * 1983-10-24 1986-10-08 "PHARLYSE", Société Anonyme Pharmaceutical tablets with prolonged action, their preparation and their use

Also Published As

Publication number Publication date
PT66201A (en) 1977-03-01
AU2255477A (en) 1978-08-31
GB1569036A (en) 1980-06-11
PT66201B (en) 1978-11-07
ZA771079B (en) 1978-01-25
DE2707763A1 (en) 1977-09-01
AU516531B2 (en) 1981-06-11
NL7701869A (en) 1977-08-25
FR2341305B1 (en) 1981-01-16
GR70334B (en) 1982-09-17
BE851702A (en) 1977-06-16

Similar Documents

Publication Publication Date Title
FR2348201A1 (en) NEW DRUGS FOR THE TREATMENT OF ISCHEMIC VASCULAR DISORDERS
BE854416A (en) PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF SYMPTOMS OF MENOPAUSE AND THEIR METHOD OF USE
MA18939A1 (en) PROCESS FOR THE PREPARATION OF AN AGENT FOR THE TREATMENT OF THEILERIOSES
FR2333515A1 (en) PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF CALCIUM METABOLISM DISORDERS
FR2341305A1 (en) NEW TABLETS AND NEW COMPOSITION FOR THE TREATMENT OF DISORDERS OF THE CEREBRAL CIRCULATORY SYSTEM, AND THEIR PREPARATION
OA07002A (en) Pyrrolidine derivative, its preparation and therapeutic uses for the treatment of cerebral insufficiency.
FR2310769A1 (en) MEDICINAL PRODUCT FOR THE TREATMENT OF ALOPECIA SEBORRHOEICA
BE856740A (en) NEW DRUG COMPOSITION FOR THE TREATMENT OF BILIARY LITHIASIS
BE871753A (en) NEW THERAPEUTIC USE OF ACETYL-1-CARNITINE FOR THE TREATMENT OF HEART CONDITIONS
FR2310751A1 (en) NEW USEFUL MEDICINES FOR THE TREATMENT OF PIG DYSENTERY
FR2311553A1 (en) MEDICINE FOR THE TREATMENT OF SCHIZOPHRENIA
FR2296415A1 (en) PHARMACEUTICAL PREPARATIONS FOR THE TREATMENT OF CIRCULATION DISORDERS
BE856006A (en) NEW MEDICINES FOR THE TREATMENT OF LIPID OVERLOAD AND CELLULITE
BE865891A (en) NEW PHARMACEUTICAL COMPOSITIONS INTENDED IN PARTICULAR FOR THE TREATMENT OF CEREBRAL FUNCTIONAL DISORDERS
RO79428A2 (en) DRUG COMPOSITION FOR THE TREATMENT OF DERMATOSES
FR2310770A1 (en) MEDICINAL PRODUCT FOR THE TREATMENT OF ALOPECIA AREATA
FR2575158B1 (en) ARYLALCOYLOXYMETHYL-2 MORPHOLINS, THEIR PREPARATION AND THEIR APPLICATION AS MEDICAMENTS USEFUL IN THE TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS
FR2310768A1 (en) MEDICINE FOR THE TREATMENT OF ALOPECIA SENILIS
BE860239A (en) MEDICINAL PREPARATION FOR THE TREATMENT OF MALIGNANT NEOFORMATIONS
BE883791A (en) PYRROLIDINE- (2) -ONE (1) -YLE-ALCOYLCARBOXYLIC ACID AMIDES, THEIR PREPARATION AND THEIR USE FOR THE TREATMENT OF CEREBRAL IRRIGATION DISORDERS
FR2496655B1 (en) THIOCARNITINES, PROCESS FOR THEIR PREPARATION AND THEIR THERAPEUTIC USE, IN PARTICULAR IN THE TREATMENT OF POISONING AND HEPATIC DISORDERS, THE TREATMENT OF BURNS AND EPITHELIUM DISEASES
FR2576M (en) New drug, in particular for the treatment of blood coagulability disorders.
BE885496A (en) THERAPEUTIC COMPOSITIONS FOR THE TREATMENT OF GLAUCOMA AND THEIR PREPARATION
BE861326A (en) BENZISOTHIAZOLONES FOR THE PROPHYLACTIC AND THERAPEUTIC TREATMENT OF TROMBOTIC DISORDERS
LU79691A1 (en) COMPOSITIONS FOR THE TREATMENT OF GASTROINTESTINAL DISORDERS AND METHOD OF PREPARATION

Legal Events

Date Code Title Description
ST Notification of lapse